Plant Physiology, Vol. 145, No. 4 (Dec., 2007), pp. 1211-1219 (9 pages) The development of novel transformation vectors is essential to the improvement of plant transformation technologies. Here, we ...
Less than two months after OXB revealed an equity raise of 60 million pounds sterling ($81 million) as part a plan to expand its operations in the U.S., the U.K.-based cell and gene therapy ...
Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and Abecma, Bristol Myers Squibb is rethinking its operations at the site. BMS ...